From ideas to long-term studies: 3D printing clinical trials review - Takeaways - MDSpire

From ideas to long-term studies: 3D printing clinical trials review

  • By

  • Jan Witowski

  • Mateusz Sitkowski

  • Tomasz Zuzak

  • Jasamine Coles-Black

  • Jason Chuen

  • Piotr Major

  • Michał Pdziwiatr

  • May 22, 2018

  • 0 min

Share

  • 1

    3D printing (3DP) in medicine faces adoption challenges due to high costs, segmentation difficulties, and insufficient scientific evidence.

  • 2

    Only a few randomized and cohort studies exist on 3DP, primarily in Maxillofacial Surgery, Orthopedics, and some in Cardiology.

  • 3

    This review analyzed 92 clinical trials registered globally, indicating a significant increase in 3DP research since 2015.

  • 4

    Orthopedics is the leading field for 3DP trials, followed by Dentistry and Maxillofacial Surgery, with most trials based in China.

  • 5

    The IDEAL framework illustrates the transition of 3DP from early feasibility studies to serious implementation and long-term studies.

Original Source(s)

Related Content